<?xml version="1.0" encoding="UTF-8"?>
<ref id="B285-plants-09-01244">
 <label>285.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Creagh</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Ruckle</surname>
    <given-names>J.L.</given-names>
   </name>
   <name>
    <surname>Tolbert</surname>
    <given-names>D.T.</given-names>
   </name>
   <name>
    <surname>Giltner</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Eiznhamer</surname>
    <given-names>D.A.</given-names>
   </name>
   <name>
    <surname>Dutta</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Flavin</surname>
    <given-names>M.T.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>Z.-Q.</given-names>
   </name>
  </person-group>
  <article-title>Safety and pharmacokinetics of single doses of (+) âˆ’ calanolide a, a novel, naturally occurring nonnucleoside reverse transcriptase inhibitor, in healthy, human immunodeficiency virus-negative human subjects</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2001</year>
  <volume>45</volume>
  <fpage>1379</fpage>
  <lpage>1386</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.45.5.1379-1386.2001</pub-id>
  <?supplied-pmid 11302799?>
  <pub-id pub-id-type="pmid">11302799</pub-id>
 </element-citation>
</ref>
